Whilst glutamine dependency has been confirmed in TNBC, there remains a need to explore the role of GLS isoforms in luminal Oestrogen receptor-positive (ER + ) and human epidermal growth factor receptor 2-negative (HER2-) breast tumours which show higher glutamine metabolic activity in in vitro studies [16]. Here, GLS is linked to breast neoplasm.